| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/17/2002 | US6495588 Administering a scytoneman compound for treating, preventing, or inhibiting a tissue hyperplasia in a subject; antiprotozoa agents |
| 12/17/2002 | US6495587 Tricyclic indole-2-carboxylic acid compound used as NMDA receptor antagonist |
| 12/17/2002 | US6495586 Scytonemin and methods of using thereof |
| 12/17/2002 | US6495585 Method for treating hyperproliferative tissue in a mammal |
| 12/17/2002 | US6495584 Use of 3-(1H-imidazol-4-ylmethyl)-indan-5-ol in the manufacture of a medicament for intraspinal, intrathecal or epidural administration |
| 12/17/2002 | US6495582 Erk (extracellular signal regulated kinase) inhibitors for treatment of cancer, inflammatory disorders, restenosis, and cardiovascular disease |
| 12/17/2002 | US6495581 Drug for treating diabetes mellitus, hyperlipemia, impaired glucose tolerance, arterial sclerosis and improving insulin resistance, inflammatory disease |
| 12/17/2002 | US6495579 Administering to a multiple sclerosis patient a therapeutically effective amount of a paclitaxel formulation contining a homo or copopolymer |
| 12/17/2002 | US6495574 Polyhydroxylated monocyclic N-heterocyclic derivatives as anti-coagulants |
| 12/17/2002 | US6495573 Non-systemic control of parasites |
| 12/17/2002 | US6495571 Administering to the mammal an effective cancer treatment amount of the compound 3,5-dichloro-4,6-diethoxy-2-(trichloromethyl)pyridine or and acid addition salt to treat the cancer |
| 12/17/2002 | US6495570 Combination drug therapy for glycolipid storage diseases |
| 12/17/2002 | US6495568 Treatment of tissue ulceration, wound repair and skin diseases |
| 12/17/2002 | US6495567 Triaryl methane compounds and their use in the treatment of diarrhea and scours |
| 12/17/2002 | US6495566 Potent antagonists at the strychnine insensitive glycine binding site associated with the n-methylaspartic acid receptor complex |
| 12/17/2002 | US6495565 For therapy of acute infection, acute phase response, age related macular degeneration, alcoholism, anorexia, asthma, autoimmune disease, autoimmune hepatitis, bechet's disease, cachexia, calcium pyrophosphate dihydrtate deposition |
| 12/17/2002 | US6495564 Such as 3-(6-((4-chloro-phenyl)-hydroxy-(3-methyl-3h-imidazol-4-yl)-methyl)-1-methyl-2-oxo-1,2-dihydro-quinolin-4-yl)-benzaldehyde o-methyl-oxime; inhibiting abnormal cell growth |
| 12/17/2002 | US6495563 Method and composition for prevention of scar formation in glaucoma filtration bleb and drainage fistula |
| 12/17/2002 | US6495560 10,11-dihydro-3-(2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)-1 -ethoxy)-5h-dibenzo(a,d)cycloheptene-10-acetic acid; treatment of osteoporosis |
| 12/17/2002 | US6495559 For therapy of obesity |
| 12/17/2002 | US6495557 Condensed thienopyrimidines with phosphodiesterase-v inhibiting action |
| 12/17/2002 | US6495556 Treating leukemia and lymphoma, sunburn and skin cancer |
| 12/17/2002 | US6495555 Tricyclic Δ-3-piperidines as α2-antagonists |
| 12/17/2002 | US6495554 Phosphodiesterase v inhibitors, treating cardiovascular disorders, and therapy of erectile dysfunction. |
| 12/17/2002 | US6495553 Methods and compositions for overcoming resistance to biologic and chemotherapy |
| 12/17/2002 | US6495552 Treatment or prevention of the diseases and conditions which respond to treatment by retinoids and or which in healthy mammals, including humans, are controlled by natural retinoic acid. |
| 12/17/2002 | US6495551 Substituted phenyloxazolidinones and their use as antibiotics |
| 12/17/2002 | US6495550 Substituted benzamido-pyridine derivatives for treatment of disorders mediated by potassium channels |
| 12/17/2002 | US6495549 1-heteroaryl-piperidine derivatives; moderating neuronal degeneration; promoting neuronal regeneration and outgrowth; treatog neurological disorders arising from neurodegenerative diseases or other disorders involving nerve damage |
| 12/17/2002 | US6495547 Hampered or impaired relaxation of the fundus to food ingestion; irritable bowel syndrome, anorexia, bloating, early satiety, dyspepsia |
| 12/17/2002 | US6495546 Propanolamine derivatives |
| 12/17/2002 | US6495545 1,4-benzodiazepinone derivatives and their use as integrin antagonists |
| 12/17/2002 | US6495544 Homoiminopiperidinyl hexanoic acid inhibitors of inducible nitric oxide synthase |
| 12/17/2002 | US6495543 Treating or preventing melatoninergic disorders |
| 12/17/2002 | US6495542 Such as 2-methoxy-n-(2-methyl-1h-benzimidazol-4-yl)-4-(2,3,4,5-tetrahydro-5-oxo-1h-1-benzazepin-1-yl)carbonyl-benzam ide; hypertension, heart failure, renal insufficiency, edema, ascites, vasopressin parasecretion syndrome |
| 12/17/2002 | US6495541 Tricyclic inhibitors of poly(ADP-ribose) polymerases |
| 12/17/2002 | US6495540 Lactams as inhibitors of A-β protein production |
| 12/17/2002 | US6495538 Apoptosis therapy |
| 12/17/2002 | US6495537 Method for inhibition of photocarcinogenesis or photoimmunosuppression using niacin |
| 12/17/2002 | US6495536 Fat or oil composition |
| 12/17/2002 | US6495535 Prefilled syringes or ampules for self administration containing dissolved carbon dioxide or nitrogen to retard oxidative degradation |
| 12/17/2002 | US6495534 Stabilized aqueous suspensions for parenteral use |
| 12/17/2002 | US6495532 Compositions containing lysophosphotidic acids which inhibit apoptosis and uses thereof |
| 12/17/2002 | US6495531 Use of glucosamine and glucosamine derivatives for quick alleviation of itching or localized pain |
| 12/17/2002 | US6495530 Composition for treating a patient susceptible to or suffering from a cardiovascular disorder or disease |
| 12/17/2002 | US6495529 Relieving nasal and bronchial congestion; inducing pupil dilation; free of side effects caused by (+)-pseudoephedrine |
| 12/17/2002 | US6495528 Antiinflammatory agents; inhibiting leukocyte recruitment and activation; agonists of adenosine 2a receptor |
| 12/17/2002 | US6495526 Inhibitors of cell-cycle progression and uses related thereto |
| 12/17/2002 | US6495525 N-((4-(((2-methylphenylamino)carbonyl)amino)phenyl)acetyl)-l -prolyl-3-methyl)-beta-alanine; very late antigen-4 cell adhesion inhibitor; inflammation and immune reactions |
| 12/17/2002 | US6495524 Benzo[b]pyran derivatives useful as external agents for the skin |
| 12/17/2002 | US6495523 Anticonvulsants; stroke, head trauma, spinal injury, non-fatal cardiac arrest, surgery |
| 12/17/2002 | US6495522 Substituted alpha-hydroxy acid caspase inhibitors and the use thereof |
| 12/17/2002 | US6495519 Interleukin-1 β converting enzyme like apoptosis protease-3 and 4 |
| 12/17/2002 | US6495517 Cyclooxygenase inhibitor |
| 12/17/2002 | US6495514 Administering such as n-acetyl-phenylalanyl-acrylic acid; inhibiting amidation of a neuropeptide; peptidylglycine alpha-monooxygenase inhibition |
| 12/17/2002 | US6495359 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor |
| 12/17/2002 | US6495346 Do not react with foreign partners; amino acids inserted into proteins which naturally form dimers, mutated proteins only form complexes with themselves (homodimers) or with the mutated partner (heterodimers), not with nonmutated starting |
| 12/17/2002 | US6495331 Regulation of cytokine production such that allergic inflammation is thereby treated by administering a compound which interacts with mekk/jnkk signal transduction pathway |
| 12/17/2002 | US6495173 Administering yeasts, coenzyme q10 and tocopherols as antilipemic agents for prevention of cardiovascular disorders |
| 12/17/2002 | US6495171 Interleukin-4 production inhibitors |
| 12/17/2002 | US6495170 Method of increasing the presence of glutathione in cells |
| 12/17/2002 | US6495166 Microencapsulation of risperidones or bupivacaine using glycolic acid-lactic acid copolymers and solvent emulsions to form sustained or time-release agents |
| 12/17/2002 | US6495165 Eplerenone compositions having improved bioavailability |
| 12/17/2002 | US6495164 Preparation of injectable suspensions having improved injectability |
| 12/17/2002 | US6495162 Controlled release oral tablet having a unitary core |
| 12/17/2002 | US6495160 Biphasic multicomponent pharmaceutical dosage forms containing substances able to modify the partitioning of drugs |
| 12/17/2002 | US6495159 Transdermal preparation containing serotonin receptor antagonist |
| 12/17/2002 | US6495158 Acne patch |
| 12/17/2002 | US6495157 Starage stable suppositories comprising antibiotics in form of drug particles dispersed in fats used for treatment of urogenital disorders |
| 12/17/2002 | US6495155 Injectable opioid partial agonist or opioid antagonist microparticle compositions and their use in reducing consumption of abused substances |
| 12/17/2002 | US6495154 On demand administration of clomipramine and salts thereof to treat premature ejaculation |
| 12/17/2002 | US6495148 High molecular weight polyuronic acids used as moisturizers and for prevention of skin disorders, ulcers, wrinkles, dryness or aging |
| 12/17/2002 | US6495147 Uses of D-xylose, the esters thereof and oligosaccharides containing xylose for improving the functionality of epidermal cells |
| 12/17/2002 | US6495142 Administering a composition comprising a specified low-molecular weight chitosan and/or a derivative |
| 12/17/2002 | US6495126 Treatment and composition for achieving skin anti-aging benefits by corneum protease activation |
| 12/17/2002 | US6495124 Compositions are used for the treatment of onychomycosis. |
| 12/17/2002 | US6495120 Formulation and system for intra-oral delivery of pharmaceutical agents |
| 12/17/2002 | CA2303591C Method and compositions for preventing or reducing hiv infection |
| 12/17/2002 | CA2260311C Remedy for cag repeat expansion diseases |
| 12/17/2002 | CA2250420C Combinations of vasopressin and adrenergic agents for the treatment of cardiac arrest |
| 12/17/2002 | CA2246560C Methods of administering an ampa receptor antagonist to treat dyskinesias associated with dopamine agonist therapy |
| 12/17/2002 | CA2216569C Use of oxazolidinone derivatives as anti-penetrating agents in a cosmetic and/or dermatological composition |
| 12/17/2002 | CA2208110C Ultraviolet-protecting cosmetic compositions containing tio2 nanopigments and an acylaminoacid |
| 12/17/2002 | CA2204616C Ppar gamma antagonists for treating obesity |
| 12/17/2002 | CA2203389C Bicyclic heterocyclic compounds for the treatment of impotence |
| 12/17/2002 | CA2188688C Use of lanthanide, tin, zinc, manganese, yttrium, cobalt, barium, strontium salt in a skin care composition |
| 12/17/2002 | CA2165520C P substance antagonist used in a pharmaceutical composition |
| 12/17/2002 | CA2153340C Application of riluzole in the treatment of parkinson's desease and parkinsonian syndromes |
| 12/17/2002 | CA2148652C Substance p antagonist used in a cosmetic composition; composition thus produced |
| 12/17/2002 | CA2144398C Composition containing a non photocatalytic metal oxide and tocopherol; use thereof in cosmetic and/or dermatological applications and processes implementing said composition |
| 12/17/2002 | CA2132636C Rapamycin formulation for iv injection |
| 12/17/2002 | CA2131822C Use of estriol for treating climacteric osteoporosis |
| 12/17/2002 | CA2095223C Topical compositions for transdermal delivery of prodrug derivatives of morphine |
| 12/17/2002 | CA2085464C Using 5,10,15,10-tetrakis (r-carboxyphenyl)porphine for detecting and treating lung cancer |
| 12/17/2002 | CA2069153C Pharmaceutical composition |
| 12/17/2002 | CA2068957C Pharmaceutical composition |
| 12/17/2002 | CA2064783C Cytoprotective fatty moiety compounds |
| 12/17/2002 | CA2062091C Pharmaceutical compositions and uses of water-soluble, high-viscosity grade cellulose ethers |
| 12/17/2002 | CA2061675C Quinoline-containing ketoacids as leukotriene antagonists |
| 12/17/2002 | CA2060491C Compositions and method for modulating eicosanoid mediated immune responses in invertebrates |